Secondary prevention of ischemic heart disease could have a huge impact on the global epidemic of cardiovascular disease. Here Ginés Sanz and Valentin Fuster consider the value of a 'polypill' for secondary prevention, examine the most efficacious combination of agents and explore whether widespread use could improve adherence and improve treatment affordability in low-income countries.
- Ginés Sanz
- Valentin Fuster